Adventitial Mast Cells Contribute to Pathogenesis in the Progression of Abdominal Aortic Aneurysm

Abdominal aortic aneurysm (AAA) is histologically characterized by medial degeneration and various degrees of chronic adventitial inflammation, although the mechanisms for progression of aneurysm are poorly understood. In the present study, we carried out histological study of AAA tissues of patients, and interventional animal and cell culture experiments to investigate a role of mast cells in the pathogenesis of AAA. The number of mast cells was found to increase in the outer media or adventitia of human AAA, showing a positive correlation between the cell number and the AAA diameter. Aneurysmal dilatation of the aorta was seen in the control (+/+) rats following periaortic application of calcium chloride (CaCl2) treatment but not in the mast cell–deficient mutant Ws/Ws rats. The AAA formation was accompanied by accumulation of mast cells, T lymphocytes and by activated matrix metalloproteinase 9, reduced elastin levels and augmented angiogenesis in the aortic tissue, but these changes were much less in the Ws/Ws rats than in the controls. Similarly, mast cells were accumulated and activated at the adventitia of aneurysmal aorta in the apolipoprotein E–deficient mice. The pharmacological intervention with the tranilast, an inhibitor of mast cell degranulation, attenuated AAA development in these rodent models. In the cell culture experiment, a mast cell directly augmented matrix metalloproteinase 9 activity produced by the monocyte/macrophage. Collectively, these data suggest that adventitial mast cells play a critical role in the progression of AAA.

[1]  S. Tamura,et al.  Medial and adventitial macrophages are associated with expansive atherosclerotic remodeling in rabbit femoral artery. , 2008, Histology and histopathology.

[2]  Peter Libby,et al.  Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. , 2007, The Journal of clinical investigation.

[3]  P. Libby,et al.  Mast cells promote atherosclerosis by releasing proinflammatory cytokines , 2007, Nature Medicine.

[4]  A. Zernecke,et al.  Perivascular Mast Cells Promote Atherogenesis and Induce Plaque Destabilization in Apolipoprotein E–Deficient Mice , 2007, Circulation.

[5]  M. Aoki,et al.  Hypertension Accelerated Experimental Abdominal Aortic Aneurysm Through Upregulation of Nuclear Factor &kgr;B and Ets , 2006, Hypertension.

[6]  Toshiyuki Shimizu,et al.  Effect of tranilast on matrix metalloproteinase production from neutrophils in‐vitro , 2006, The Journal of pharmacy and pharmacology.

[7]  M M Thompson,et al.  A review of biological factors implicated in abdominal aortic aneurysm rupture. , 2005, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[8]  G. Ailawadi,et al.  Neutrophil Depletion Inhibits Experimental Abdominal Aortic Aneurysm Formation , 2005, Circulation.

[9]  G. Upchurch,et al.  Management of abdominal aortic aneurysms , 2005, Current treatment options in cardiovascular medicine.

[10]  M. Tsai,et al.  Mast cells enhance T cell activation: Importance of mast cell-derived TNF. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Åbrink,et al.  A Key Role for Mast Cell Chymase in the Activation of Pro-matrix Metalloprotease-9 and Pro-matrix Metalloprotease-2* , 2005, Journal of Biological Chemistry.

[12]  K. Hatakeyama,et al.  Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensin II-induced hypertensive rats. , 2005, Cardiovascular research.

[13]  Yuan Zhang,et al.  Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-beta. , 2005, Cardiovascular Research.

[14]  B. Baxter,et al.  Elastin Degradation and Calcification in an Abdominal Aorta Injury Model: Role of Matrix Metalloproteinases , 2004, Circulation.

[15]  Yuan Zhang,et al.  Tranilast attenuates structural and functional aspects of renal injury in the remnant kidney model. , 2004, Journal of the American Society of Nephrology : JASN.

[16]  Jilly F. Evans,et al.  The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm , 2004, Nature Medicine.

[17]  Simon G. Thompson,et al.  Abdominal Aortic Aneurysm Expansion: Risk Factors and Time Intervals for Surveillance , 2004, Circulation.

[18]  J. Marshall,et al.  Mast cells in innate immunity. , 2004, The Journal of allergy and clinical immunology.

[19]  T. Greiner,et al.  Key Roles of CD4+ T Cells and IFN-γ in the Development of Abdominal Aortic Aneurysms in a Murine Model1 , 2004, The Journal of Immunology.

[20]  C. Liapis,et al.  Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms , 2004, Current medical research and opinion.

[21]  E. Ocaña,et al.  Characterisation of T and B lymphocytes infiltrating abdominal aortic aneurysms. , 2003, Atherosclerosis.

[22]  A. Ichikawa,et al.  Uptake of histamine by mouse peritoneal macrophages and a macrophage cell line, RAW264.7. , 2003, American journal of physiology. Cell physiology.

[23]  S. Kawasaki,et al.  Overexpression of transforming growth factor beta1 in smooth muscle cells of human abdominal aortic aneurysm. , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[24]  J. Burnett,et al.  Brain Natriuretic Peptide Is Produced in Cardiac Fibroblasts and Induces Matrix Metalloproteinases , 2002, Circulation research.

[25]  Timothy C Greiner,et al.  Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. , 2002, The Journal of clinical investigation.

[26]  K. Kanmatsuse,et al.  The impact of tranilast on restenosis after coronary angioplasty: the Second Tranilast Restenosis Following Angioplasty Trial (TREAT-2). , 2002, American heart journal.

[27]  T. Sakurai,et al.  Four strains of spontaneously hyperlipidemic (SHL) mice: phenotypic distinctions determined by genetic backgrounds. , 2001, Journal of atherosclerosis and thrombosis.

[28]  R. Hershkoviz,et al.  Human Mast Cells Release Metalloproteinase-9 on Contact with Activated T Cells: Juxtacrine Regulation by TNF-α1 , 2001, The Journal of Immunology.

[29]  M. Isobe,et al.  Tranilast Inhibits Cardiac Allograft Vasculopathy in Association With p21Waf1/Cip1 Expression on Neointimal Cells in Murine Cardiac Transplantation Model , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[30]  M. Babina,et al.  Mast cells as initiators of immunity and host defense , 2001, Experimental dermatology.

[31]  M. Murakami,et al.  Role of cytosolic phospholipase A2 in the production of lipid mediators and histamine release in mouse bone-marrow-derived mast cells. , 2000, The Biochemical journal.

[32]  K. Angquist,et al.  Activity of matrix metalloproteinase-2 and -9 in abdominal aortic aneurysms. Relation to size and rupture. , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[33]  D. Leszczyński,et al.  Mast Cell Chymase Induces Apoptosis of Vascular Smooth Muscle Cells , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[34]  J. Hallett,et al.  Management of abdominal aortic aneurysms. , 2000, Mayo Clinic proceedings.

[35]  G. Nilsson,et al.  Human mast cell migration in response to members of the transforming growth factor‐β family , 2000, Journal of leukocyte biology.

[36]  S. Hayashi,et al.  Spontaneously hyperlipidemic (SHL) mice: Japanese wild mice with apolipoprotein E deficiency , 1999, Mammalian Genome.

[37]  Pelkonen,et al.  Mast cells in psoriatic skin are strongly positive for interferon‐gamma , 1999, The British journal of dermatology.

[38]  M. Nishida,et al.  Migration of neutrophils is dependent on mast cells in nonspecific pleurisy in rats , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[39]  H. Miyata,et al.  Tranilast : A new application in the cardiovascular field as an antiproliferative drug , 1998 .

[40]  M. Ward,et al.  Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptors in injured arteries. , 1998, Atherosclerosis.

[41]  Möller,et al.  Comparative cytokine gene expression: regulation and release by human mast cells , 1998, Immunology.

[42]  S A Wickline,et al.  Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. , 1997, The American journal of pathology.

[43]  K. Ichikawa,et al.  Tranilast suppresses the vascular intimal hyperplasia after balloon injury in rabbits fed on a high-cholesterol diet. , 1996, European journal of pharmacology.

[44]  R. Sayers,et al.  Angiogenesis in abdominal aortic aneurysms. , 1996, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[45]  J. Powell,et al.  Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[46]  R. Mecham,et al.  Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. , 1995, The Journal of clinical investigation.

[47]  K. Tohya,et al.  Characterization of cultured mast cells derived from Ws/Ws mast cell-deficient rats with a small deletion at tyrosine kinase domain of c-kit. , 1994, Blood.

[48]  R. Virmani,et al.  The association of mast cells and atherosclerosis: a morphologic study of early atherosclerotic lesions in young people. , 1994, Human pathology.

[49]  J. Lohi,et al.  Pericellulars substrates of human mast cell tryptase: 72,000 Dalton gelatinase and fibronectin , 1992, Journal of cellular biochemistry.

[50]  G. Chejfec,et al.  Correlation of inflammatory infiltrate with the enlargement of experimental aortic aneurysms. , 1992, Journal of vascular surgery.

[51]  E. Morii,et al.  Characterization of Ws mutant allele of rats: a 12-base deletion in tyrosine kinase domain of c-kit gene. , 1991, Blood.

[52]  Y. Kitamura,et al.  Anemia and mast cell depletion in mutant rats that are homozygous at "white spotting (Ws)" locus. , 1991, Blood.

[53]  Y. Urade,et al.  Inhibitory effect of tranilast on prostaglandin D synthetase. , 1989, Biochemical pharmacology.

[54]  Eisenberg,et al.  Aneurysm of the rabbit common carotid artery induced by periarterial application of calcium chloride in vivo. , 1988, The Journal of clinical investigation.

[55]  R. Bell,et al.  Contribution of macrophages to immediate hypersensitivity reaction. , 1986, Journal of immunology.

[56]  C. Machado,et al.  Cerebral vasospasm: presence of mast cells in human cerebral arteries after aneurysm rupture. , 1981, Journal of neurosurgery.

[57]  H. Azuma,et al.  PHARMACOLOGICAL PROPERTIES OF N‐(3′,4′‐DIMETHOXYCINNAMOYL) ANTHRANILIC ACID (N‐5′), A NEW ANTI‐ATOPIC AGENT , 1976, British journal of pharmacology.

[58]  D. Chi,et al.  The human mast cell: an overview. , 2006, Methods in molecular biology.

[59]  H. Takagi,et al.  Smoking promotes pathogenesis of aortic aneurysm through the 5-lipoxygenase pathway. , 2005, Medical hypotheses.

[60]  S. Toda,et al.  Mast cells and angiogenesis , 2003, Microscopy research and technique.

[61]  G. Milon,et al.  Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1alpha /beta released from neutrophils recruited by mast cell-derived TNFalpha. , 2003, Blood.

[62]  伊澤 淳 Tranilast inhibits cardiac allograft vasculopathy in association with p21Waf1/Cip1 expression on neointimal cells in murine cardiac transplantation model , 2001 .

[63]  M. Nakazawa,et al.  Study of the mechanism of inhibitory action of tranilast on chemical mediator release. , 1988, Japanese journal of pharmacology.